Josef Schoell
2014
In 2014, Josef Schoell earned a total compensation of $623.8K as Chief Financial Officer at Cara Therapeutics, a 204% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $73,150 |
|---|---|
| Option Awards | $341,684 |
| Salary | $209,000 |
| Total | $623,834 |
Schoell received $341.7K in option awards, accounting for 55% of the total pay in 2014.
Schoell also received $73.2K in non-equity incentive plan and $209K in salary.
Rankings
In 2014, Josef Schoell's compensation ranked 9,527th out of 13,032 executives tracked by ExecPay. In other words, Schoell earned more than 26.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,527 out of 13,032 | 27th |
Division Manufacturing | 3,600 out of 4,966 | 28th |
Major group Chemicals And Allied Products | 1,227 out of 1,686 | 27th |
Industry group Drugs | 970 out of 1,365 | 29th |
Industry Pharmaceutical Preparations | 744 out of 1,043 | 29th |
Source: SEC filing on April 24, 2015.
Schoell's colleagues
We found four more compensation records of executives who worked with Josef Schoell at Cara Therapeutics in 2014.